查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1628060

左心耳封堵器市場機會、成長促進因素、產業趨勢分析與預測 2024 - 2032 年

Left Atrial Appendage Closure Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 131 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年，全球左心耳封堵器械市場價值為18 億美元，預計將經歷顯著成長，2024 年至2032 年複合年成長率預計為19.2%。 、醫療技術的不斷進步是推動這一市場擴張的關鍵驅動力。

市場主要分為兩類產品：心內膜左心耳裝置及心外膜左心耳裝置。其中，心內膜左心耳裝置佔據最大佔有率，2023年產值達16億美元。這些裝置因其能夠減少血栓栓塞事件的發生，同時保持良好的手術併發症風險狀況而廣受認可。此外，心內膜左心耳封堵裝置被視為與心房顫動消融手術結合的可靠選擇。

就最終用戶而言，市場分為醫院、門診手術中心和其他醫療機構。醫院細分市場將在 2023 年佔據主導地位，預計到預測期結束時將達到 60 億美元。由於擴大使用具有卓越可操作性的先進左心耳閉合裝置，醫院繼續引領市場，這可能會提高患者對這些設定的偏好。需要治療心房顫動的患者數量不斷增加，加上疾病篩檢工作的增加和醫療基礎設施的改善，進一步支持了這個細分市場的擴張。隨著醫療保健系統的改善，心房顫動在已開發市場和新興市場的流行也有望推動醫院市場的成長。

市場範圍
開始年份 2023年
預測年份 2024-2032
起始值 18億美元
預測值 88億美元
複合年成長率 19.2%

北美左心耳封堵器市場 2023 年營收為 13 億美元，預計 2024 年至 2032 年複合年成長率為 17.6%。主要產業參與者繼續推動新設備的開發和商業化創新，進一步加強市場的擴張。心房顫動盛行率的不斷上升以及隨後住院人數的增加將繼續推動該地區對左心耳封堵器的需求。

在技​​術創新、疾病盛行率上升以及各種醫療保健環境中擴大採用這些設備的推動下，左心耳封堵設備市場將實現強勁成長。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 心房顫動的盛行率不斷增加
      • 強大的產品管線
      • 增加政府舉措
      • 左心耳封堵器的技術進步
    • 產業陷阱與挑戰
      • 替代技術的存在
      • LAA 封堵器成本高
  • 成長潛力分析
  • 監管環境
  • 報銷場景
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 戰略儀表板

第 5 章：市場估計與預測：按產品分類，2021 - 2032 年

  • 主要趨勢
  • 心內膜左心耳裝置
  • 心外膜左心耳裝置

第 6 章：市場估計與預測：按程序，2021 - 2032

  • 主要趨勢
  • 經皮
  • 外科

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

  • 主要趨勢
  • 醫院
  • 門診手術中心
  • 其他最終用戶

第 8 章：市場估計與預測：按地區，2021 - 2032

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 9 章：公司簡介

  • Abbott Laboratories
  • AtriCure
  • Boston Scientific Corporation
  • Lepu Medical Technology
  • LifeTech Scientific
  • MicroPort Scientific Corporation
  • Nanjing YDB Technology
  • Shanghai Push Medical Device Technology
簡介目錄
Product Code: 3960

The Global Left Atrial Appendage Closure Devices Market was valued at USD 1.8 billion in 2023 and is projected to experience significant growth, with an estimated CAGR of 19.2% from 2024 to 2032. The rising incidence of atrial fibrillation (AF), supportive government policies, and continuous advancements in medical technology are key drivers contributing to this market expansion.

The market is primarily divided into two product categories: endocardial LAA devices and epicardial LAA devices. Among these, endocardial LAA devices accounted for the largest share, generating USD 1.6 billion in 2023. The growth in this segment is attributed to the increasing demand for devices that effectively minimize the risk of blood clots from the left atrial appendage entering the bloodstream. These devices are widely recognized for their ability to reduce the occurrence of thromboembolic events while maintaining a favorable risk profile for procedural complications. Additionally, endocardial LAA closure devices are seen as a reliable option in combination with atrial fibrillation ablation procedures.

In terms of end users, the market is segmented into hospitals, ambulatory surgical centers, and other healthcare facilities. The hospital segment dominated in 2023 and is expected to reach USD 6 billion by the end of the forecast period. Hospitals continue to lead the market due to the increasing use of advanced LAA closure devices that offer superior operability, which is likely to boost patient preference for these settings. The growing number of patients requiring treatment for AF, coupled with a rise in disease screening efforts and improved healthcare infrastructure, further supports the expansion of this segment. The prevalence of AF in both developed and emerging markets with improving healthcare systems is also expected to drive hospital-based market growth.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$1.8 Billion
Forecast Value$8.8 Billion
CAGR19.2%

North America market for LAA closure devices generated USD 1.3 billion in revenue in 2023 and is projected to grow at a CAGR of 17.6% from 2024 to 2032. Factors such as the presence of leading manufacturers, rising demand for LAA closure products, and the growing number of AF cases are pivotal to this market's robust growth. Key industry players continue to drive innovation in the development and commercialization of new devices, further reinforcing the market's expansion. The increasing prevalence of atrial fibrillation and the subsequent rise in hospital admissions will continue to fuel the demand for LAA closure devices in the region.

The left atrial appendage closure device market is positioned for strong growth, driven by technological innovations, rising disease prevalence, and increasing adoption of these devices in various healthcare settings.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of atrial fibrillation
      • 3.2.1.2 Strong product pipeline
      • 3.2.1.3 Increasing government initiatives
      • 3.2.1.4 Technological advancements in left atrial appendage closure devices
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Presence of alternate technologies
      • 3.2.2.2 High cost of LAA closure devices
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Reimbursement scenario
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn & Units)

  • 5.1 Key trends
  • 5.2 Endocardial LAA devices
  • 5.3 Epicardial LAA devices

Chapter 6 Market Estimates and Forecast, By Procedure, 2021 - 2032 ($ Mn & Units)

  • 6.1 Key trends
  • 6.2 Percutaneous
  • 6.3 Surgical

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn and Units)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers
  • 7.4 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn and Units)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Abbott Laboratories
  • 9.2 AtriCure
  • 9.3 Boston Scientific Corporation
  • 9.4 Lepu Medical Technology
  • 9.5 LifeTech Scientific
  • 9.6 MicroPort Scientific Corporation
  • 9.7 Nanjing YDB Technology
  • 9.8 Shanghai Push Medical Device Technology